参考文献/References:
[1] PENZIAS A,AZZIZ R,BENDIKSON K,et al.Testing and interpreting measures of ovarian reserve:A committee opinion[J].Fertil and Steril,2020,114(6):1151-1157.
[2] JIAO Z,BUKULMEZ O.Potental roles of experimental reproductive technolodies in infertile women with diminished ovarian reserve[J].J Assist Reorod Cenet,2021,38:2507-2517.
[3] GAO H,GAO L,RAO Y,et al.The Gengnianchun recipe attenuates insulin resistance-induced diminished ovarian reserve through inhibiting the senescence of granulosa cells[J].Front Endocrinol,2023,14:1133280.
[4] LU X,LV X,DONG X,et al.Increased serine synthesis in cumulus cells of young infertile women with diminished ovarian reserve[J].Hum Reprod,2023,38(9):1723-1732.
[5] 卵巢储备功能减退临床诊治专家共识专家组,中华预防医学会生育力保护分会生殖内分泌生育保护学组.卵巢储备功能减退临床诊治专家共识[J].生殖医学杂志,2022,31(4):425-434.
[6] 梁学梅,闫颖.中医治疗卵巢储备功能下降研究进展[J].时珍国医国药,2021,32(7):1720-1723.
[7] FERRARETTI A P,LA MARCA A,FAUSER B,et al.ESHRE consensus on the definition of ‘poor response' to ovarian stimulation for in vitro fertilization:The Bologna criteria[J].Hum Reprod,2011,26(7):1616-1624.
[8] 谈勇.中医妇科学[M].北京:中国中医药出版社,2016:135-140.
[9] 国家中医药管理局.中医病证诊断疗效标准[M].北京:中国医药科技出版社,2012:229-230.
[10] 国家食品药品监督管理局.中药新药临床研究指导原则(试行)[M].北京:中国中医药出版社,2002:239-243.
[11] ZHU Q,LI Y,MA J,et al.Potential factors result in diminished ovarian reserve:A comprehensive review[J].J Ovarian Res,2023,16(1):208.
[12] DOGAN S,CICEK O S Y,DEMIR M,et al.The effect of growth hormone adjuvant therapy on assisted reproductive technologies outcomes in patients with diminished ovarian reserve or poor ovarian response[J].J Gynecol Obstet Hum Reprod.2021,50(2):101982.
[13] PATRIZIO P,VAIARELLI A,LEVI SETTI P E,et al.How to define,diagnose and treat poor responders?Responses from a worldwide survey of IVF clinics[J].Reprod Biomed Online,2015,30(6):581-592.
[14] 中华中医药学会妇科分会.和颜坤泰胶囊临床应用专家指导意见[J].中草药,2020,51(8):2075-2081.
[15] ZHANG X,ZHANG L,XIONG L,et al.Kuntai capsule for the treatment of diminished ovarian reserve:A systematic review and meta-analysis of randomized controlled trials[J].J Ethnopharmacol,2024,329:118167.
[16] 胡淑玲,王韫琪,田丹.温经汤加减治疗肾虚血瘀型卵巢储备功能减退疗效及对患者子宫动脉血流和卵巢功能的影响[J].陕西中医,2023,44(10):1395-1399.
[17] 顾雨婷,梁程程,沈聪,等.知柏地黄丸治疗卵巢储备功能低下不孕疗效研究[J].陕西中医,2022,43(10):1376-1379.
[18] XU Z,RUAN X,XU X,et al.Efficacy and safety of Zi Gui Nv Zhen capsules used in TCM for fertility preservation in patients with diminished ovarian reserve[J].Gynecol Endocrinol,2022,38(1):73-77.
[19] Practice Committee of the American Society for Reproductive Medicine.Testing and interpreting measures of ovarian reserve:A committee opinion[J].Fertil Steril,2020,114(6):1151-1157.
[20] 周洪梅,董金菊,马梦玲.AMH联合E2、FSH/LH检测对不孕症患者卵巢储备功能及反应性的评估作用[J].中国性科学,2020,29(8):71-75.
[21] 宗政,胡扬,徐蓓蕾,等.基于UPLC-Q-TOF-MS和网络药理学探讨菟丝子-枸杞子药对治疗早发性卵巢功能不全的成分及机制[J].中成药,2025,47(2):649-658.
[22] WANG Y,WU J,LI Y,et al.Polysaccharides of fructus corni improve ovarian function in mice with aging-associated perimenopause symptoms[J]. Evid Based Complement Alternat Med,2019,2019(1):8-17.
[23] IWASE A,HASEGAWA Y,TSUKUI Y,et al.Anti-Mullerian hormone beyond an ovarian reserve marker:The relationship with the physiology and pathology in the life-long follicle development[J].Front Endocrinol,2023,14:1273966.
[24] PELLICER N,COZZOLINO M,DIAZ-GARCIA C,et al.Ovarian rescue in women with premature ovarian insufficiency:Facts and fiction[J].Reprod Biomed Online,2023,46(3):543-565.
[25] ZHOU J,PAN X Y,LIN J,et al.Effects of Bushen Yiqi Huoxue decoction in treatment of patients with diminished ovarian reserve:A randomized controlled trial[J].Chin J Integr Med,2022,28(3):195-201.
[26] ZHU F,GAO J,ZENG F,et al.Hyperoside protects against cyclophosphamide induced ovarian damage and reduced fertility by suppressing HIF-1α/BNIP3-mediated autophagy[J].Biomed Pharmacother,2022,156:113743.
[27] LI Y,LIU F,LI S,et al.Association of variants in vascular endothelial growth factor A gene and VEGFA serum levels with the risk of primary ovarian insufficiency:A case-control study[J].Gynecol Obstet Invest,2021,86(5):469-476.
[28] GARNETT E R,RAINES R T.Emerging biological functions of ribonuclease 1 and angiogenin[J].Crit Rev Biochem Mol Biol,2022,57(3):244-260.
相似文献/References:
[1]邱美江,谢秀梅.加味四物二仙汤治疗卵巢储备功能减退临床研究[J].陕西中医,2021,(7):860.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.011]
[2]胡淑玲,王韫琪,田 丹.温经汤加减治疗肾虚血瘀型卵巢储备功能减退疗效及对患者子宫动脉血流和卵巢功能的影响[J].陕西中医,2023,(10):1395.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.013]
HU Shuling,WANG Yunqi,TIAN Dan.Effect of modified Wenjing decoction on uterine artery blood flow and ovarian function in patients with ovarian hypofunction due to kidney deficiency and blood stasis[J].,2023,(4):1395.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.013]
[3]陈 梅,陈 茜,党慧敏,等.补肾调经方联合脱氢表雄酮治疗卵巢储备功能减退临床研究[J].陕西中医,2025,46(2):188.[doi:DOI:10.3969/j.issn.1000-7369.2025.02.008]
CHEN Mei,CHEN Qian,DANG Huimin,et al.Clinical efficacy of Bushen Tiaojing formula combined with dehydroepiandrosterone in the treatment of diminished ovarian reservation patients[J].,2025,46(4):188.[doi:DOI:10.3969/j.issn.1000-7369.2025.02.008]